Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: FASEB J. 2021 Oct;35(10):e21865. doi: 10.1096/fj.202100325RR

Figure 11. Inhibition of HDAC6 activity decreases levels of PC2.

Figure 11.

(A and C) mIMCD3 (WT and Pkd1KO) and PRE (WT and Pkd1KO) cells were treated with Tubastatin-A (T) for 18 hours and proteins were isolated for Western Blot analysis with the indicated antibodies. (B) Quantification of PC2 expression in (A). PC2 level in untreated WT cells was set to 1. (D) Quantification of PC2 expression in (C). PC2 level in untreated WT cells was set to 1. The bars represent mean ± SEM. *p<0.05, **p<0.01, ***p < 0.001.